Barbara Sahakian (Professor of Clinical Neuropsychology, Department of Psychiatry, University of Cambridge School of Clinical Medicine)
Cognitive enhancers (aka ‘smart drugs’) are already being prescribed for patients with neuropsychiatric disorders and brain injury.
However, off-label use of these ‘smart drugs’ is becoming increasingly common, as people become aware of substances that can help them study longer and work more effectively.
Part of the Health and Welfare Research Group seminar series.
For more information about the group, please visit the link on the right hand side of this page.